Compound Summary
药名: | salvianolic acid a |
别名: | 4CN-1253; AC-20308; 3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)vinyl]-3,4-dihydroxy-phenyl]prop-2-enoyl]oxy-propanoic acid; SCHEMBL10041475; (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl]prop-2-enoyl]oxypropanoic acid; 2-(3,4-Dihydroxystyryl)-3,4-dihydroxycinnamic acid alpha-carboxy-3,4-dihydroxyphenethyl ester; Benzenepropanoic acid, a-[[(2E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl]-1-oxo-2-propenyl]oxy]-3,4-dihydroxy-; Dimethyl methyldopa HCL; Salvianolicacid A; (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)vinyl]-3,4-dihydroxy-phenyl]prop-2-enoyl]oxy-propanoic acid; AKOS015965219; 3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl]prop-2-enoyl]oxypropanoic acid; (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)vinyl]-3,4-dihydroxy-phenyl]acryloyl]oxy-propionic acid; AC1O1L81; Benzenepropanoic acid, alpha-((3-(2-(2-(3,4-dihydroxyphenyl)ethenyl)-3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (R-(E,E))-; BC216311; Salvianolic acid A; 96574-01-5; (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)vinyl]-3,4-dihydroxyphenyl]-1-oxoprop-2-enoxy]propanoic acid; (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxy-phenyl]prop-2-enoyl]oxy-propanoic acid; salvianolicacid a; C10492 |
分子式: | C26H22O10 |
Smiles: | C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=C(C(=C(C=C2)O)O)C=CC3=CC(=C(C=C3)O)O)O)O |
成分: | HBIN042900 |
OB_score: | 2.956732 |
CAS_id: | 96574-01-5 |
SymMap_id: | SMIT00681;SMIT17547 |
TCMID_id: | 23238;19186 |
TCMSP_id: | MOL007136 |
PubChem_id: | 5281793 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE001266 | 白花甘西鼠尾草 | |||||
TCMBANKHE001571 | Caulis Clematidis Armandii | 川木通 | To remove heat and induce diuresis, to stimulate menstrual discharge, and promote lactation./Treatment of edema, stranguria oliguria, arthralgia, amenorrhea, lack of lactation. | |||
TCMBANKHE003752 | Radix Salviae liguliobae | 丹参 | To remove blood stasis and relieve pain, to promote the flow of blood and stimulate menstrual discharge, and to ease the mind./Angina pectoris, cerebral atherosclerosis, diffusive intravascular clotting, thrombophlebitis, hepatitis, acute surgical infection, mastitis, erysipelas, otitis media, tonsillitis, bone marrow infection, menstrual disorder, dysmenorrhea, amenorrhea, postpartum stasis stagnation abdominal pain, pain in heart and abdomen, concretion conglomeration accumulation and gathering, heat impediment swelling and pain, knocks and falls, heat entering construction-blood, vexation and agitation, insomnia and vexation, swelling toxin of welling abscess and sore, zoster, neurodermatitis, psoriasis. | |||
TCMBANKHE003770 | Musa paradisiaca | 粉芭蕉 | ||||
TCMBANKHE004250 | Theobroma cacao | 可可 | To warm yang, disinhibit urine, raise spirit. | |||
TCMBANKHE005020 | Annona reticulata | 牛心番荔枝 | To clear heat and check dysentery, expel worms./Heat toxin dysentery, intestinal parasitic disease. | |||
TCMBANKHE005484 | Tournefortia sarmentosa | 紫丹藤 | ||||
TCMBANKHE008921 | Salvia miltiorrhiza f. alba | 白花丹参 | See Salvia miltiorrhiza ./See Salvia miltiorrhiza. | |||
TCMBANKHE005432/YNS-47/YEM-51/XU-527 | Salvia przewalskii|Salvia przewalskii Maxim.var.mandarinorum(Diels) Stib.|Salvia przewalskii Maxim. | 甘西鼠尾草|褐毛甘西鼠尾|甘西鼠尾 | 大紫丹参|甘西鼠尾 | 云南药材标准:第七册|云南民族药物志:第一卷|西藏昌都市芒康县 | 活血化瘀,通经止痛,清心安神。用于胸痹心痛,心烦失眠,脘腹胁痛,痛经、经闭、产后恶露不尽,风湿痹痛,癥瘕,疮疡肿痛。|See Salvia miltiorrhiza ./See Salvia miltiorrhiza . | 彝族/藏族 |
TCMBANKHE003980/YEM-928 | Aconitum carmichaeli|Aconitum carmichaeli Debx. | 乌头 | 乌头 | 云南民族药物志:第五卷 | To dispel wind and eliminate damp, warm channels, dissipate cold and relieve pain./Wind-cold-damp impediment, pain in joints, numbness in limbs, hemiplegia, head wind headache, cold pain in heart and abdomen, cold mounting with pain, stasis pain from knocks and falls, swelling toxin of flat abscess. | 阿昌族/布依族/傣族/德昂族/回族/景颇族/傈僳族/苗族/水族/彝族 |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
TCMBANKDI000085 | Inflammation | phenotype | Pathological Conditions, Signs and Symptoms | 24033467 |
TCMBANKDI001795 | Reperfusion Injury | disease | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 31193821 |
TCMBANKDI010048 | Pneumonia | disease | Infections; Respiratory Tract Diseases | 31969071 |
TCMBANKDI015290 | Cerebral Ischemia | disease | Nervous System Diseases; Cardiovascular Diseases | 31193821 |
TCMBANKDI015830 | Myocardial Ischemia | disease | Cardiovascular Diseases | 30361065 |
TCMBANKDI023904 | Macular degeneration | disease | Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases | 24486344 |
TCMBANKDI031985 | Brain Ischemia | disease | Nervous System Diseases; Cardiovascular Diseases | 27609227 |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000047 | AKT1 | AKT; CWS6; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA | AKT serine/threonine kinase 1 |
TCMBANKGE000294 | CDKN1A | CAP20; CDKN1; CIP1; MDA-6; P21; SDI1; WAF1; p21CIP1 | cyclin dependent kinase inhibitor 1A |
TCMBANKGE001045 | CCND1 | BCL1; D11S287E; PRAD1; U21B31 | cyclin D1 |
TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
TCMBANKGE001166 | BCL2 | Bcl-2; PPP1R50 | BCL2 apoptosis regulator |
TCMBANKGE003300 | EIF6 | CAB; EIF3A; ITGB4BP; b(2)gcn; eIF-6; p27(BBP); p27BBP | eukaryotic translation initiation factor 6 |
TCMBANKGE003643 | F7 | SPCA | coagulation factor VII |
TCMBANKGE009234 | COL7A1 | EBD1; EBDCT; EBR1; NDNC8 | collagen type VII alpha 1 chain |
TCMBANKGE010213 | HERC5 | CEB1; CEBP1 | HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
TCMBANKGE011079 | PRSS1 | TRP1; TRY1; TRY4; TRYP1 | serine protease 1 |